| Ytd | 156.36% | |
| 1y | 139.54% |
| Open | 19.10 | Prev Close | 19.08 | Low | 19.01 | High | 19.75 | Mkt Cap | 506.32M |
| Vol | 50.93K | Avg Vol | 274.24K | EPS | -1.31 | P/E | -14.56 | Forward P/E | -4.77 |
| Beta | -0.24 | Short Ratio | 5.30 | Inst. Own | 6.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 14.71 | 200-d Avg | 9.46 | 1yr Est | 22.00 |
NVCT News
US stock futures higher with Nasdaq 100 up 150 points. Ryanair (RYAAY) shares fall after weak Q1 res
New report covers Nuvectis Pharma (NASDAQ: NVCT) as the company transitions from a single-drug oncol
The consensus price target hints at a 61.5% upside potential for Nuvectis Pharma (NVCT). While empir
Top Wall Street analysts changed their outlook on these top names. For a complete view of all rating
Roth Capital analyst Jonathan Aschoff maintains Nuvectis Pharma (NASDAQ:NVCT) with a Buy and rais
Does Nuvectis Pharma, Inc. (NVCT) have what it takes to be a top stock pick for momentum investors?
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday&#
Gainers Abivax (NASDAQ:ABVX) shares increased by 36.0% to $130.74 during Tuesday's pre-market s
US stock futures up, Dow futures gain 100+ points. Concentrix Corp (CNXC) shares down 24% after weak
AeroVironment, Inc. (NASDAQ: AVAV) jumped 21.4% in pre-market trading after reporting strong financi
Nuvectis intends to use the net proceeds from the offering to continue to advance the development pr
FORT LEE, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical s
Gainers Gain Therapeutics (NASDAQ:GANX) stock rose 20.2% to $2.38 during Monday's after-market
Nuvectis Pharma, Inc. (NASDAQ:NVCT), a clinical stage biopharmaceutical company focused on the devel
FORT LEE, NJ, June 29, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical sta
Nuvectis Pharma (NVCT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about
Gainers Pulsenmore (NASDAQ:PLSM) shares moved upwards by 160.5% to $8.88 during Wednesday's reg
NVCT stock jumped after Nuvectis expanded its pipeline through a licensing deal with Haisco.
HC Wainwright & Co. analyst Joseph Pantginis maintains Nuvectis Pharma (NASDAQ:NVCT) with a B
Nuvectis Pharma, Inc. (NVCT) Discusses Strategic In-Licensing Deal and Expansion Into Complement-Med
Nuvectis Pharma said on Monday it had licensed exclusive rights outside China to two experimental dr
Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage
Fort Lee, NJ, June 22, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or
The mean of analysts' price targets for Nuvectis Pharma (NVCT) points to a 57% upside in the stock.
Fort Lee, NJ, May 14, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or t
The average of price targets set by Wall Street analysts indicates a potential upside of 62.5% in Nu
FORT LEE, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or
Fort Lee, NJ, March 31, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or
FORT LEE, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" o
Nuvectis Pharma, Inc. (NASDAQ: NVCT - Get Free Report) shot up 5.8% on Wednesday. The company traded
Nuvectis Pharma, Inc. (NASDAQ: NVCT - Get Free Report)'s stock price rose 0.5% on Friday. The compan
The study is designed to evaluate the safety and clinical activity of NXP900 in combination with osi
Fort Lee, NJ, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT, the “Company”),
FORT LEE, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Nov